BLC
GH icon

Brown, Lisle/Cummings’s Guardant Health GH Stock Holding History

Brown, Lisle/Cummings’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-285
Closed -$14.8K – 771
2025
Q2 		$14.8K Hold
285
– – ﹤0.01% 455
2025
Q1 		$12.1K Hold
285
– – ﹤0.01% 470
2024
Q4 		$8.71K Hold
285
– – ﹤0.01% 499
2024
Q3 		$6.54K Buy
285
+200
+235% +$5.66K ﹤0.01% 498
2024
Q2 		$2.46K Buy
+85
New +$1.98K ﹤0.01% 555

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown, Lisle/Cummings's GH Position: Q3 2025 in Review

Brown, Lisle/Cummings sold out of Guardant Health (GH) in Q3 2025, closing a stake of 285 shares — an estimated $14.8K sold.

Brown, Lisle/Cummings first reported a position in GH in Q2 2024 and held it in 5 quarters. The position peaked at $14.8K in Q2 2025. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Brown, Lisle/Cummings reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • Brown, Lisle/Cummings sold 285 Guardant Health shares in Q3 2025, an estimated $14.8K.
  • Brown, Lisle/Cummings first reported a position in Guardant Health in Q2 2024 and held it in 5 quarters.
  • Brown, Lisle/Cummings's Guardant Health position peaked at $14.8K in Q2 2025.
  • 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Brown, Lisle/Cummings's 13F filing for Q3 2025, filed 10 Oct 2025.